S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
Log in

Phreesia Stock Price, News & Analysis (NYSE:PHR)

$27.06
+0.13 (+0.48 %)
(As of 10/15/2019 04:00 PM ET)
Today's Range
$26.66
Now: $27.06
$27.97
50-Day Range
$23.48
MA: $26.11
$28.15
52-Week Range
$22.05
Now: $27.06
$29.38
Volume329,714 shs
Average Volume299,950 shs
Market Capitalization$967.69 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, including through Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients, healthcare provider organizations, and life sciences companies. The company was founded in 2005 and is headquartered in New York, New York.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone888-654-7473

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees436
Market Cap$967.69 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PHR News and Ratings via Email

Sign-up to receive the latest news and ratings for PHR and its competitors with MarketBeat's FREE daily newsletter.


Phreesia (NYSE:PHR) Frequently Asked Questions

What is Phreesia's stock symbol?

Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR."

What guidance has Phreesia issued on next quarter's earnings?

Phreesia issued an update on its FY 2020 earnings guidance on Monday, September, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $118.5-119 million, compared to the consensus revenue estimate of $117.71 million.

What price target have analysts set for PHR?

6 brokers have issued 12 month price objectives for Phreesia's stock. Their forecasts range from $23.00 to $33.00. On average, they anticipate Phreesia's stock price to reach $30.60 in the next twelve months. This suggests a possible upside of 13.5% from the stock's current price. View Analyst Price Targets for Phreesia.

What is the consensus analysts' recommendation for Phreesia?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Phreesia.

Has Phreesia been receiving favorable news coverage?

News articles about PHR stock have been trending neutral on Tuesday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Phreesia earned a news impact score of 0.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Phreesia.

Are investors shorting Phreesia?

Phreesia saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 1,000,000 shares, an increase of 33.4% from the August 30th total of 749,700 shares. Based on an average daily volume of 426,400 shares, the short-interest ratio is presently 2.3 days. Approximately 9.8% of the company's shares are short sold. View Phreesia's Current Options Chain.

Who are some of Phreesia's key competitors?

What other stocks do shareholders of Phreesia own?

Who are Phreesia's key executives?

Phreesia's management team includes the folowing people:
  • Mr. Chaim Indig, Co-Founder, CEO & Director (Age 41)
  • Mr. Evan Roberts, Co-Founder & COO (Age 40)
  • Mr. Thomas Altier, Chief Financial Officer (Age 69)
  • Mr. Daniel Nathan, Chief Technology Officer (Age 43)
  • Mr. Charles H. N. Kallenbach J.D., Gen. Counsel & Sec. (Age 56)

When did Phreesia IPO?

(PHR) raised $127 million in an initial public offering on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO.

When does Phreesia's lock-up period expire?

Phreesia's lock-up period expires on Tuesday, January 14th. Phreesia had issued 9,288,194 shares in its initial public offering on July 18th. The total size of the offering was $167,187,492 based on an initial share price of $18.00. After the end of Phreesia's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

How do I buy shares of Phreesia?

Shares of PHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Phreesia's stock price today?

One share of PHR stock can currently be purchased for approximately $26.95.

How big of a company is Phreesia?

Phreesia has a market capitalization of $963.73 million. Phreesia employs 436 workers across the globe.View Additional Information About Phreesia.

What is Phreesia's official website?

The official website for Phreesia is http://www.phreesia.com/.

How can I contact Phreesia?

Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The company can be reached via phone at 888-654-7473 or via email at [email protected]


MarketBeat Community Rating for Phreesia (NYSE PHR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  19
MarketBeat's community ratings are surveys of what our community members think about Phreesia and other stocks. Vote "Outperform" if you believe PHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel